Neurology Minute

In the final episode of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss when and where to use clinical metagenomic next-generation sequencing tests, as well as the limitations of these tests.  Show reference:  https://www.nature.com/articles/s41591-024-03275-1 

In part nine of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss the findings from this study and the implications for global vaccine strategy.  Show reference:  https://pubmed.ncbi.nlm.nih.gov/40086461/     

In part two of this two-part series, Dr. Stacey Clardy and Casey R. Vanderlip discuss the changes that neurologists should implement in their clinics based on the findings from this study regarding APOE genotype.  Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213853  

In part one of this two part series, Dr. Stacey Clardy and Casey R. Vanderlip discuss what neurologists need to know about how APOE4 and amyloid interact to impact cognitive function.  Show reference:  https://www.neurology.org/doi/10.1212/WNL.0000000000213853 

Dr. Halley Alexander and Dr. Juan Luis Alcala-Zermeno discuss the outcomes of epilepsy surgery, specifically for patients with tonic-clonic seizures.  Show references:  https://onlinelibrary.wiley.com/doi/10.1111/epi.18243  https://onlinelibrary.wiley.com/doi/full/10.1111/epi.17452  https://directory.libsyn.com/episode/index/id/26286819 

In this episode of the Neurology Minute, Dr. Alison Christy delves into another women's history minute to discuss Tilly Edinger. 

In the August episode of the President's Spotlight, Dr. Jason Crowell and Dr. Natalia Rost discuss the mid-year assessment of AAN's five-year strategic plan.  Show reference:  https://www.aan.com/about-the-aan/presidents-spotlight   

In the third episode of this series, Dr. Andy Southerland discusses the latest Capitol Hill Report, which outlines the 2026 Medicare fee schedule proposal.  Stay updated with what’s happening on the hill by visiting aan.com/chr.  Learn how you can get involved with AAN advocacy. 

Dr. Kathryn Krulisky and Dr. Jordan Garris discuss educational gaps in understanding FND, the impact of stigma on patient care, and the importance of empathy in medical training.  Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200219 

Dr. Shuvro Roy and Dr. Daniel Blockmans discuss the efficacy and safety of upadacitinib as a treatment option for giant-cell arteritis.  Show reference:  https://www.nejm.org/doi/10.1056/NEJMoa2413449 

In part eight of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss the study findings and the potential impact on clinical practice.  Show reference:  https://jamanetwork.com/journals/jamaneurology/fullarticle/2824325

In part seven of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss how to counsel patients about getting care abroad.  Show reference:  https://academic.oup.com/cid/article/78/6/1554/7280488

In part six of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss findings from a recent systematic review on pneumococcal meningitis, including the role of corticosteroid, the importance of treatment timing, and emerging adjunctive therapies that may improve patient outcomes. Show reference:  https://academic.oup.com/braincomms/article/6/3/fcae131/7644484

Dr. Jason Crowell discusses clinical considerations when addressing cognitive concerns in patients with Parkinson disease.  Show reference:  https://www.neurology.org/doi/10.1212/WNL.0000000000209699  https://directory.libsyn.com/episode/index/id/32642512 

Dr. Dan Ackerman and Dr. James Ernest Siegler discuss the complexities of treating ESUS and emphasize the importance of personalized treatment approaches based on individual patient factors.  Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213876 

In part five of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss the study findings and when clinicians should maintain suspicion for parechovirus.  Show reference:  https://academic.oup.com/cid/article-abstract/79/6/1479/7726317?redirectedFrom=fulltext 

In the second episode of this two-part series, Dr. Justin Abbatemarco and Dr. Eric L. Voorn discuss how to integrate these coaching elements into practice to promote sustainable changes.  Show reference:  https://www.neurology.org/doi/10.1212/WNL.0000000000213781  https://www.sciencedirect.com/science/article/pii/S0960896625000458?via%3Dihub 

In the second episode of this series, Dr. Andy Southerland discusses the latest Capitol Hill Report, breaking down what a reconciliation bill is and why it matters.  Stay updated with what’s happening on the hill by visiting aan.com/chr.  Learn how you can get involved with AAN advocacy. 

Dr. Trey Bateman and Dr. Gregg Day discuss the study design, findings, and clinical implications of using plasma biomarkers in real-world patient care.  Show reference: https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.70316 

In part one of this two-part series, Dr. Justin Abbatemarco and Dr. Eric L. Voorn discuss how exercise remains essential for people with neuromuscular disorders, even amid limited pharmaceutical options and safety concerns.  Show reference:  https://www.neurology.org/doi/10.1212/WNL.0000000000213781 https://www.sciencedirect.com/science/article/pii/S0960896625000458?via%3Dihub